Related Experiment Video
Updated: Jan 8, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
NLRP3 Inflammasome Activation Modulates Neutrophil Extracellular Trap Formation and Aggravates Airway Inflammation in
Zhao-Ming Chen1, Jia-Hui He1,2, Rui-di Tang1,3
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Joint International Research Laboratory of Respiratory Health, Guangdong Basic Research Center of Excellence for Respiratory Medicine, Department of Allergy and Clinical Immunology, Department of Respiratory and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510163, P. R. China.
None:
Neutrophilic inflammation and Pseudomonas aeruginosa infection have been implicated in the pathogenesis and progression of bronchiectasis. However, the mechanisms underlying the inflammasome activation and neutrophil extracellular traps (NETs) formation, which are triggered by lipopolysaccharide (LPS), thereby fostering relentless neutrophilic inflammation and airway destruction, remain poorly understood. Here, we investigated how nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation modulates NET formation, epithelial inflammation, and injury in bronchiectasis. Compared with those in the stable state, interleukin-1β levels in the exacerbation state were greater and were correlated with blood neutrophil counts. LPS triggered neutrophil NLRP3 inflammasome activation and induced NET formation. At exacerbation, caspase-1 p20, DNA-myeloperoxidase, and DNA-neutrophil elastase expression levels were increased compared with those in the stable state. LPS triggered the first signal, nuclear factor-κB, for NLRP3 inflammasome activation within the airway epithelium, leading to neutrophil chemotactic factor release. NETs served as the secondary signal for thorough NLRP3 inflammasome activation. Acting synergistically with LPS, NETs amplified epithelial inflammation, up-regulating mucin 5AC expression while suppressing zona occludens-1 and α-tubulin expression. Both MCC950 and Z-VAD-FMK inhibited NLRP3 inflammasome activation, whereas GSK484 and LDC7559 suppressed NET formation. Collectively, NLRP3 inflammasome activation facilitates NET formation in bronchiectasis, aggravating inflammation and eliciting injury to epithelial cells.
More Related Videos
12:27The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
06:52Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.